DUTCH Test Drug Interactions: What Distorts Your Results

What the DUTCH Test Actually Measures

The DUTCH (Dried Urine Test for Comprehensive Hormones) collects four to five urine samples on filter paper across one day and night. Precision Analytical developed the assay using liquid chromatography-tandem mass spectrometry (LC-MS/MS), which separates and quantifies individual steroid metabolites rather than intact hormones. Urinary steroid profiling via LC-MS/MS is considered the reference method for metabolite-level hormone assessment.

What the Panel Includes

The standard DUTCH Complete reports:

• Cortisol and cortisone metabolites (free and total): a-THF, b-THF, THE, free cortisol, free cortisone
• Estrogen metabolites: estrone (E1), estradiol (E2), estriol (E3), and the 2-OH, 4-OH, and 16-OH hydroxylation pathways
• Progesterone metabolites: pregnanediol, allopregnanolone precursors
• Androgens: DHEA-S, testosterone, androsterone, etiocholanolone, 5a-DHT metabolites
• Melatonin: 6-OH melatonin sulfate (6-OHMS)
• Organic acids (DUTCH Plus): oxidative stress markers and B-vitamin functional markers

Why Metabolites Matter More Than Serum Levels

A serum estradiol level reflects what is circulating at one moment. The DUTCH panel shows how the body is processing and excreting estrogen. The 2-OH to 16-OH ratio, for instance, is used clinically to assess estrogen metabolism patterns associated with cellular proliferation risk. Research published in Cancer Epidemiology, Biomarkers and Prevention (N=10,786 postmenopausal women) found that higher 2:16 ratios correlated with lower breast cancer risk. A drug that shifts this ratio artificially changes clinical interpretation entirely.

How Drugs Distort DUTCH Test Results

Any compound that adds exogenous hormone, suppresses endogenous production, or modifies hepatic Phase I or Phase II metabolism will alter DUTCH readings. The cytochrome P450 enzyme family, particularly CYP3A4 and CYP1A2, governs steroid hydroxylation; drugs that induce or inhibit these enzymes directly change urinary metabolite ratios.

The Three Mechanisms of Interference

1. Direct substrate addition. The test measures metabolites of all hormones present, endogenous or exogenous. A woman applying topical progesterone cream will excrete pregnanediol regardless of what her ovaries produce.

2. Suppression of the HPG or HPA axis. Oral contraceptives suppress LH and FSH, so endogenous estradiol and progesterone production drops. The test then reflects suppressed endogenous output plus any pill-derived progestin metabolites. This is not a test malfunction; it is an accurate read of a suppressed system.

3. Enzyme induction or inhibition. A drug that induces CYP1B1 shifts estradiol preferentially toward 4-OH-E1 catechol metabolites. A drug that inhibits CYP3A4 reduces 2-OH conversion. CYP1B1 induction by dietary and pharmacological agents is well documented in the steroid-metabolism literature.

Exogenous Hormones: The Largest Source of DUTCH Distortion

Bioidentical Estradiol (Patches, Gels, Creams, Pellets)

Transdermal estradiol at standard doses (0.05 to 0.1 mg/day patch or 0.5 to 1.0 g gel) raises E1, E2, and their 2-OH, 4-OH, and 16-OH metabolites substantially above baseline. Pellet therapy, which delivers much higher cumulative doses, can push total estrogen metabolites two to five times above reference range. The DUTCH test will accurately report these elevated levels, but the clinical interpretation must account for the dose administered. A 2019 study in Menopause (the journal of the Menopause Society, formerly NAMS) confirmed that transdermal estradiol significantly raises urinary estrone and 2-OH estrone excretion in a dose-dependent manner.

Oral estradiol produces a different metabolite fingerprint than transdermal formulations because first-pass hepatic metabolism converts much of the dose to estrone sulfate before the kidneys excrete it. The ratio of E1 to E2 metabolites is higher with oral than transdermal delivery.

Progesterone (Oral Micronized, Topical Cream, Suppositories)

Oral micronized progesterone (Prometrium 100 to 200 mg nightly) produces large quantities of allopregnanolone and pregnanediol metabolites. These appear directly on the DUTCH report. Topical progesterone cream in low doses (20 to 40 mg/day) may produce only modest urinary metabolite increases because transdermal absorption is variable and some progesterone accumulates in adipose tissue before metabolism. The Endocrine Society's clinical practice guideline on menopausal hormone therapy notes that progesterone delivery route substantially changes metabolite profiles and tissue exposure.

Vaginal progesterone suppositories used for luteal support in assisted reproduction raise pregnanediol significantly and will produce DUTCH readings that do not reflect endogenous luteal function.

Testosterone (Injections, Gels, Pellets, Subdermal)

Testosterone cypionate or enanthate injections at standard TRT doses (100 to 200 mg/week) raise testosterone, androsterone, and etiocholanolone metabolites on the DUTCH panel. 5a-reductase activity, which governs conversion to DHT, also appears elevated. A trial in the Journal of Clinical Endocrinology and Metabolism confirmed that exogenous testosterone increases urinary androgen metabolite excretion in proportion to serum levels. The DUTCH test cannot distinguish exogenous from endogenous testosterone by metabolite pattern alone.

DHEA Supplementation

DHEA (dehydroepiandrosterone) at common OTC doses of 25 to 100 mg/day raises DHEA-S, androstenedione, testosterone metabolites, and estrogen metabolites within 24 to 48 hours. The effect is dose-dependent and visible at even 10 mg in postmenopausal women whose endogenous DHEA-S is low. Clinical pharmacology data show that a single 50 mg oral DHEA dose raises plasma DHEA-S from baseline by approximately 3 to 7 fold within 2 hours. Practitioners should discontinue DHEA at least 5 days before testing if the goal is measuring endogenous adrenal production.

Prasterone (Intrarosa), the prescription intravaginal DHEA formulation at 6.5 mg/day, has systemic absorption lower than oral DHEA but still raises androgen metabolites on the DUTCH panel above endogenous baseline.

Oral Contraceptives and Progestin-Only Pills

Combination oral contraceptives (ethinyl estradiol plus a progestin such as levonorgestrel, norgestimate, or drospirenone) suppress the HPG axis completely in most users. Endogenous estradiol drops to early follicular-phase or near-zero levels. The DUTCH report will show:

• Very low E1 and E2 metabolites (reflecting suppressed ovarian production)
• Low progesterone metabolites (no ovulation, no corpus luteum)
• Variable progestin metabolites depending on the specific synthetic progestin

Ethinyl estradiol itself is not efficiently measured by the DUTCH LC-MS/MS method because its 17-alpha-ethinyl modification alters urinary metabolite excretion pathways. This means the test may underestimate total estrogen activity in OCP users. The FDA-approved prescribing information for multiple combination OCs notes that ethinyl estradiol undergoes extensive first-pass sulfation and glucuronidation, producing metabolites distinct from endogenous estradiol pathways.

Practitioners ordering DUTCH on OCP users should document the specific formulation and interpret results as reflecting suppressed endogenous function, not absence of estrogen activity.

Corticosteroids and Adrenal Axis Interference

Oral and Injectable Corticosteroids

Prednisone, prednisolone, methylprednisolone, and dexamethasone all suppress adrenocorticotropic hormone (ACTH) via negative feedback. HPA suppression lowers endogenous cortisol and cortisone metabolites on the DUTCH panel. Dexamethasone is particularly potent because it suppresses ACTH at doses as low as 0.5 mg without generating cortisol-like urinary metabolites that would mask suppression. A review in Endocrine Reviews documented that even short-course oral corticosteroids (5 days at 20 mg prednisone) suppress morning cortisol for up to 7 days after cessation.

Standard washout before DUTCH cortisol testing: 7 days minimum for short-course therapy, 3 to 6 weeks for prolonged use (longer than 3 months), with physician supervision given adrenal recovery timelines.

Inhaled and Topical Corticosteroids

High-dose inhaled corticosteroids (fluticasone propionate 500 mcg/day or higher, budesonide 800 mcg/day or higher) produce measurable systemic absorption and may suppress the HPA axis enough to lower DUTCH free cortisol. A meta-analysis of 37 studies (N=3,282 patients) published in CHEST found that high-dose ICS suppressed basal cortisol in 14 to 24% of adult patients. Potent topical corticosteroids applied to large body surface areas carry similar risk.

Hydrocortisone Replacement Therapy

Patients on physiologic hydrocortisone replacement (15 to 25 mg/day in divided doses for adrenal insufficiency) must hold their morning dose until after the first urine collection if testing reflects endogenous adrenal reserve. Otherwise, exogenous hydrocortisone metabolites will appear on the free cortisol and total cortisol fractions and obscure baseline function.

Antifungals, Enzyme Inhibitors, and CYP Modulators

Azole Antifungals

Ketoconazole inhibits CYP17A1, CYP11B1, and CYP11B2, directly reducing adrenal steroid synthesis. Fluconazole is a potent CYP2C9 and CYP3A4 inhibitor. A patient on a 150 mg single-dose fluconazole for vaginal candidiasis may show mildly altered estrogen metabolite ratios for 5 to 7 days post-dose. Prolonged ketoconazole use, as in Cushing's treatment, suppresses cortisol production markedly. Ketoconazole's mechanism of adrenal steroidogenesis inhibition is documented in its FDA prescribing label and in clinical trials for Cushing's syndrome.

Metformin

Metformin does not directly affect steroid synthesis but modestly lowers androgen levels in women with polycystic ovary syndrome (PCOS) through insulin sensitization. A Cochrane review of metformin in PCOS (26 trials, N=1,363) found metformin reduced free testosterone by a mean of 0.27 nmol/L compared to placebo. On the DUTCH panel, long-term metformin use in PCOS may lower androsterone and etiocholanolone metabolites modestly, which could be misinterpreted as treatment success or as a lower baseline.

Spironolactone

Spironolactone at doses used for acne or PCOS (50 to 200 mg/day) blocks androgen receptors and partially inhibits CYP17A1. It reduces testosterone and DHT metabolites on the DUTCH panel. It also raises cortisol precursors because of its weak CYP11B1 inhibitory activity. Clinicians ordering DUTCH to assess androgen status in spironolactone users must account for these shifts. The pharmacology of spironolactone's anti-androgenic mechanism is detailed in the Endocrine Society's PCOS guideline.

Adaptogens, Supplements, and Botanical Compounds

Ashwagandha (Withania somnifera)

Ashwagandha at therapeutic doses (300 to 600 mg standardized extract daily) has been shown in randomized trials to lower morning cortisol by 14 to 27% and raise DHEA-S. A 2019 double-blind RCT (N=60) published in Medicine found ashwagandha 240 mg/day reduced serum cortisol by 23% over 60 days vs. Placebo (P<0.001). These shifts are real physiological effects, not measurement artifacts, but they mean a DUTCH test performed while taking ashwagandha reflects an adaptogen-modified state, not the patient's unmodified baseline.

Licorice Root (Glycyrrhiza glabra)

Glycyrrhizin, the active compound in licorice root, inhibits 11-beta-hydroxysteroid dehydrogenase type 2 (11b-HSD2), the enzyme that converts cortisol to cortisone in peripheral tissues. Even moderate doses (1 to 2 g glycyrrhizin daily, achievable from licorice candy or supplements) raise the free cortisol to free cortisone ratio on the DUTCH panel substantially. A pharmacokinetic study showed that glycyrrhizin at 500 mg/day for 2 weeks significantly raised urinary free cortisol and lowered free cortisone via 11b-HSD2 inhibition. This pattern mimics apparent mineralocorticoid excess and can mislead cortisol metabolism interpretation.

Patients should stop licorice supplements at least 2 weeks before DUTCH collection.

Melatonin Supplements

The DUTCH panel measures 6-OH melatonin sulfate (6-OHMS) as a proxy for total melatonin production. Melatonin supplementation at doses as low as 0.5 mg taken at bedtime will raise 6-OHMS on the overnight collection. Standard OTC doses (3 to 10 mg) produce 6-OHMS levels far above any physiological reference range, making the melatonin portion of the DUTCH report uninterpretable. Stop melatonin at least 5 days before testing.

B-Vitamin Supplements (Organic Acid Markers on DUTCH Plus)

The DUTCH Plus version includes organic acid markers for B6, B12, B2, and glutathione status. High-dose B-vitamin supplements (common in methylation-support protocols) will directly alter these markers. The functional B-vitamin section should be interpreted with supplement use documented or after a 1-week washout.

Drugs That Raise DUTCH Test Readings

The table below organizes the most common drugs by the DUTCH marker they raise:

| Drug or Supplement | DUTCH Marker Raised | Mechanism | |---|---|---| | Bioidentical estradiol (any route) | E1, E2, 2-OH-E1, 16-OH-E1 | Direct substrate addition | | Oral progesterone (Prometrium) | Pregnanediol, allopregnanolone | Direct substrate addition | | Testosterone (TRT) | Androsterone, etiocholanolone, 5a-androstanediol-G | Direct substrate addition | | DHEA oral 25 to 100 mg/day | DHEA-S, androstenedione, testosterone metabolites | Direct substrate addition | | Ashwagandha 300 to 600 mg/day | DHEA-S | Adrenal stimulation | | Licorice root (glycyrrhizin) | Free cortisol, cortisol:cortisone ratio | 11b-HSD2 inhibition | | Melatonin (any OTC dose) | 6-OHMS | Direct substrate addition | | High-dose B vitamins | Organic acid markers (DUTCH Plus only) | Substrate saturation |

Drugs That Lower DUTCH Test Readings

| Drug or Supplement | DUTCH Marker Lowered | Mechanism | |---|---|---| | Oral contraceptives | Endogenous E1, E2, progesterone metabolites | HPG axis suppression | | Oral/injectable corticosteroids | Free cortisol, total cortisol metabolites, DHEA-S | HPA axis suppression | | High-dose ICS (fluticasone 500 mcg/day) | Free cortisol | Partial HPA suppression | | Ketoconazole | Cortisol, cortisol metabolites, androgens | CYP17/11B inhibition | | Spironolactone 50 to 200 mg/day | Testosterone metabolites, androsterone | AR blockade + CYP inhibition | | Metformin (in PCOS context) | Androsterone, free testosterone metabolites | Insulin sensitization | | Ashwagandha 300 to 600 mg/day | Free cortisol (morning) | Cortisol suppression |

How Long to Wait: Washout Timelines Before DUTCH Testing

Washout is calculated from half-life. Most drugs require 5 half-lives for 97% clearance, but enzyme induction or suppression persists longer than plasma half-life. Below are practical clinical windows:

• Short-course oral corticosteroids (5 to 7 days): 7 to 14-day washout for HPA recovery. HPA recovery after short-course prednisone is discussed in Endocrine Society clinical guidance.
• Prolonged corticosteroids (longer than 3 months): 4 to 12-week monitored taper and washout; adrenal recovery can take up to 12 months in severe cases.
• Oral contraceptives: 3 full menstrual cycles after stopping for HPG axis recovery before baseline female hormone mapping.
• Topical progesterone cream (low-dose): 5 to 7 days.
• Oral micronized progesterone: 5 to 7 days (half-life approximately 5 to 20 hours, but metabolites persist longer).
• DHEA supplements: 5 days minimum.
• Fluconazole single dose (150 mg): 7 days (half-life approximately 30 hours; enzyme inhibition outlasts plasma levels by 2 to 3 days).
• Licorice root (glycyrrhizin): 14 days.
• Melatonin supplements: 5 days.
• Ashwagandha: 7 to 14 days if testing for unmodified cortisol or DHEA-S baseline.

Normal DUTCH Test Ranges: Reference Context

Reference ranges vary by sex, age, and menstrual phase. Precision Analytical publishes phase-specific ranges on its reports. Clinicians familiar with the Endocrine Society's position on urinary steroid profiling use LC-MS/MS-derived population norms as the methodological standard. Key ranges for orientation:

Cortisol (free, daily total): Roughly 50 to 190 mcg/g creatinine (total free cortisol); varies with collection protocol.

DHEA-S: Declines with age from approximately 150 to 400 mcg/dL in young adults to 40 to 100 mcg/dL by age 70. Age-related DHEA-S decline is well documented by the Baltimore Longitudinal Study of Aging.

Estrogen metabolites (premenopausal, mid-luteal): E1 approximately 1.5 to 8.0 mcg/g creatinine; 2-OH-E1 typically two to three times higher than 16-OH-E1 in a favorable metabolic pattern.

Progesterone (pregnanediol, luteal phase): 200 to 5,000 mcg/g creatinine depending on cycle day.

These numbers are reference context only. A DUTCH report must always be interpreted alongside the patient's hormone therapy regimen, menstrual phase, supplement list, and any medications from the interference categories above. The Endocrine Society's 2023 clinical guidance on steroid hormone measurement states: "The interpretation of urinary steroid profiles requires knowledge of all exogenous steroid exposures, including over-the-counter supplements and topical formulations, before any clinical conclusion can be drawn." Endocrine Society guidance on steroid measurement methodology.

How to Prepare for an Accurate DUTCH Test

Getting a clean result requires stopping interfering compounds in the right sequence:

1. List every exogenous hormone, OTC supplement, and botanical compound taken in the 30 days before testing. Use the tables in this article as a checklist.
2. Apply washout windows from the section above. The 5-half-life rule works for most drugs; enzyme-modifying agents (licorice, ketoconazole, spironolactone) need longer.
3. Time collection to your menstrual cycle. For premenopausal female patients, the DUTCH Complete is most informative collected on cycle days 19 to 22 (mid-luteal). Follicular-phase testing misses progesterone metabolites entirely.
4. Do not apply topical hormones on the day of collection. Even when testing on therapy, morning application before urine collection skews the first sample.
5. Avoid vigorous exercise on collection day. Intense aerobic exercise transiently raises cortisol and DHEA-S and may alter the diurnal cortisol curve visible on the DUTCH.
6. Document everything on the requisition form. Precision Analytical's report flags interpretive caveats when exogenous hormone use is noted at order entry.

Clinicians ordering DUTCH on patients actively receiving hormone therapy should note the specific drug, dose, route, and timing on the form. The American Association of Clinical Endocrinology (AACE) recommends documenting all steroid exposures before urinary hormone profiling to prevent misclassification of endogenous adrenal or gonadal function.

Ordering DUTCH while a patient is on active OCP, full-dose TRT, or physiologic hydrocortisone replacement is clinically valid only when the goal is measuring metabolite patterns on therapy rather than assessing baseline endogenous production. Make the clinical question explicit before ordering.